1. Home
  2. EARN vs FENC Comparison

EARN vs FENC Comparison

Compare EARN & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EARN

Ellington Residential Mortgage REIT of Beneficial Interest

HOLD

Current Price

$4.56

Market Cap

200.3M

Sector

Real Estate

ML Signal

HOLD

Logo Fennec Pharmaceuticals Inc.

FENC

Fennec Pharmaceuticals Inc.

HOLD

Current Price

$6.40

Market Cap

266.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EARN
FENC
Founded
2012
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
200.3M
266.4M
IPO Year
2012
2010

Fundamental Metrics

Financial Performance
Metric
EARN
FENC
Price
$4.56
$6.40
Analyst Decision
Buy
Strong Buy
Analyst Count
2
3
Target Price
$5.38
$15.00
AVG Volume (30 Days)
451.7K
202.4K
Earning Date
03-04-2026
05-12-2026
Dividend Yield
20.96%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$44,642,000.00
Revenue This Year
$7.69
$75.81
Revenue Next Year
$19.57
$25.06
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.27
$4.68
52 Week High
$6.08
$9.92

Technical Indicators

Market Signals
Indicator
EARN
FENC
Relative Strength Index (RSI) 47.51 40.27
Support Level $4.43 N/A
Resistance Level $5.36 $9.09
Average True Range (ATR) 0.11 0.45
MACD 0.04 -0.08
Stochastic Oscillator 100.00 31.30

Price Performance

Historical Comparison
EARN
FENC

About EARN Ellington Residential Mortgage REIT of Beneficial Interest

Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times. The company primary investment objectives are to generate attractive current yields and risk-adjusted total returns for shareholders. It invest in multiple parts of the CLO capital structure, principally mezzanine debt and equity tranches. Rather than focusing only on short-term current yield, it select investments that it believe will provide a strong total return to drive a sustainable earnings stream over a long-term horizon.

About FENC Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

Share on Social Networks: